POT1 and Bjornstad syndrome: In conclusion, a systematic approach to assess the pathogenicity of the variants, and their clinical significance, is necessary to accurately define the clinical spectrum of POT1-PTD and to discuss, with solid data, the protocol of surveillance for POT1 variant carriers.